Covid-19: NPPA notifies medical devices as drugs to cap their prices

Our Bureau New Delhi | Updated on April 01, 2020 Published on April 01, 2020

Huge potential The Indian medical device sector is the fourth largest in Asia and is worth $5.5 billion   -  Czgur

The National Pharmaceutical Pricing Authority (NPPA) has dispelled all fears over Covid-19 causing disruption in supply of active pharmaceutical ingredients (API).

It has also increased the ceiling price of 883 scheduled formulations, in compliance of the provisions of Drugs Price Control Order (DPCO) 2013. In another change, it brought in medical devices under price control by defining them as ‘drugs’, under the DPCO. These decisions were taken at its meeting on March 31.

“The Authority noted with satisfaction that the supply disruption of APIs caused by Covid-19 outbreak is returning to normalcy and no unusual price fluctuations in price of inputs for medicines, amid virus spread have been reported. Hence, normal price revisions have been allowed,” NPPA has stated.

Increase in ceiling price is based on Wholesale Price Index (WPI), which is 1.88468 per cent, it said.

The revision in ceiling price of formulations includes the revision of ceiling price of cardiac stents also now stand at ₹8,417 for bare metal stents and ₹30,647 for drug eluting stents.

Lav Agarwal, Joint Secretary, Ministry of Health and Family Welfare, said that all 24 classes of medical devices have been relegated as drugs so that no manufacturer will increase their MRP beyond 10 per cent in a year.

Agarwal also said that under Lifeline Udan initiative of Ministry of Civil Aviation, 74 flights have been operated till date for transporting medical cargo across the country. A total of 37.63 tonnes of cargo has been transported till date out of which more than 22 tonnes has been transported on March 31.

1,637 confirmed cases

As on April 1, the Health Ministry has reported 1637 confirmed cases of Covid-19, of which 132 have been cured and 38 have died. Agarwal said, “During last 24 hours, 376 new cases have been reported, and three new deaths have been recorded.” This is the single largest spike since the beginning of the outbreak.

Meanwhile, Trade Ministers from SAARC countries have decided to meet soon to discuss a common strategy to handle trade issues amidst the disruption caused by the Covid-19 virus.

Published on April 01, 2020

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.